Pain Therapeutics Stock Price, News & Analysis (NASDAQ:PTIE)

$6.28 -0.07 (-1.10 %)
(As of 02/19/2018 04:00 PM ET)
Previous Close$6.28
Today's Range$6.27 - $6.49
52-Week Range$3.10 - $12.80
VolumeN/A
Average Volume1.31 million shs
Market Capitalization$41.42 million
P/E Ratio-3.45
Dividend YieldN/A
Beta2.83

About Pain Therapeutics (NASDAQ:PTIE)

Pain Therapeutics logoPain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company's other products is FENROCK. REMOXY is a painkiller with a formulation designed to reduce potential risks of unintended use. The Company has developed REMOXY to make oxycodone difficult to abuse yet provide approximately 12 hours of steady pain relief when used by patients. REMOXY is intended to meet the needs of healthcare prescribing opioid drugs and seeking to minimize the risks of drug diversion, abuse or accidental patient misuse. The Company's drug candidate FENROCK is an abuse-deterrent transdermal pain patch in the pre-Investigational new drug-stage of development. FENROCK is designed to provide pain relief over 72 hours.

Receive PTIE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTIE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryPharmaceuticals
SectorHealthcare
SymbolNASDAQ:PTIE
CUSIP69562K10
Phone+1-512-5012444

Debt

Debt-to-Equity RatioN/A
Current Ratio9.43%
Quick Ratio9.43%

Price-To-Earnings

Trailing P/E Ratio-3.45054945054945
Forward P/E Ratio-3.81
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.47 per share
Price / Book4.27

Profitability

Trailing EPS($1.82)
Net Income$-11,910,000.00
Net MarginsN/A
Return on Equity-93.35%
Return on Assets-86.53%

Miscellaneous

Employees9
Outstanding Shares6,590,000

Pain Therapeutics (NASDAQ:PTIE) Frequently Asked Questions

What is Pain Therapeutics' stock symbol?

Pain Therapeutics trades on the NASDAQ under the ticker symbol "PTIE."

When did Pain Therapeutics' stock split? How did Pain Therapeutics' stock split work?

Pain Therapeutics shares reverse split on Wednesday, May 10th 2017. The 1-7 reverse split was announced on Monday, May 8th 2017. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 9th 2017. An investor that had 100 shares of Pain Therapeutics stock prior to the reverse split would have 14 shares after the split.

How were Pain Therapeutics' earnings last quarter?

Pain Therapeutics, Inc. (NASDAQ:PTIE) posted its quarterly earnings data on Monday, February, 5th. The biopharmaceutical company reported ($0.37) earnings per share (EPS) for the quarter. View Pain Therapeutics' Earnings History.

When will Pain Therapeutics make its next earnings announcement?

Pain Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Pain Therapeutics.

Who are some of Pain Therapeutics' key competitors?

Who are Pain Therapeutics' key executives?

Pain Therapeutics' management team includes the folowing people:

  • Remi Barbier, Chairman of the Board, President, Chief Executive Officer (Age 56)
  • Nadav Friedmann, Chief Medical and Operating Officer, Director (Age 72)
  • Michael Marsman Pharm.D., Senior Vice President - Regulatory Affairs
  • Robert Z. Gussin Ph.D., Independent Director (Age 77)
  • Michael J. O' Donnell Esq., Independent Director (Age 56)
  • Saira Ramasastry, Independent Director (Age 40)
  • Sanford R. Robertson, Independent Director (Age 85)
  • Patrick J. Scannon M.D., Ph.D., Independent Director (Age 67)

Who owns Pain Therapeutics stock?

Pain Therapeutics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.94%). View Institutional Ownership Trends for Pain Therapeutics.

Who sold Pain Therapeutics stock? Who is selling Pain Therapeutics stock?

Pain Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Pain Therapeutics.

How do I buy Pain Therapeutics stock?

Shares of Pain Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pain Therapeutics' stock price today?

One share of Pain Therapeutics stock can currently be purchased for approximately $6.28.

How big of a company is Pain Therapeutics?

Pain Therapeutics has a market capitalization of $41.42 million. The biopharmaceutical company earns $-11,910,000.00 in net income (profit) each year or ($1.82) on an earnings per share basis. Pain Therapeutics employs 9 workers across the globe.

How can I contact Pain Therapeutics?

Pain Therapeutics' mailing address is 7801 N Capital of Texas Hwy Ste 260, AUSTIN, TX 78731-1192, United States. The biopharmaceutical company can be reached via phone at +1-512-5012444.


MarketBeat Community Rating for Pain Therapeutics (PTIE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Pain Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pain Therapeutics (NASDAQ:PTIE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellSell
Consensus Rating Score: 1.001.001.001.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$17.50
Price Target Upside: N/AN/AN/A365.43% upside

Pain Therapeutics (NASDAQ:PTIE) Consensus Price Target History

Price Target History for Pain Therapeutics (NASDAQ:PTIE)

Pain Therapeutics (NASDAQ:PTIE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017GabelliDowngradeHold -> SellLowView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Pain Therapeutics (NASDAQ:PTIE) Earnings History and Estimates Chart

Earnings by Quarter for Pain Therapeutics (NASDAQ:PTIE)

Pain Therapeutics (NASDAQ PTIE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018        
2/5/2018Q4 2017($0.37)ViewN/AView Earnings Details
11/1/2017Q3 2017($0.40)ViewN/AView Earnings Details
8/9/2017Q2 2017($0.47)($0.64)ViewN/AView Earnings Details
4/25/2017Q1 2017($0.42)($0.42)ViewN/AView Earnings Details
2/17/2017Q4 2016($0.42)ViewN/AView Earnings Details
10/20/2016Q316($0.63)($0.56)ViewN/AView Earnings Details
7/19/2016Q216($0.98)($0.49)ViewN/AView Earnings Details
5/5/2016Q1($0.70)($0.91)ViewN/AView Earnings Details
3/1/2016Q4 2015($0.70)ViewN/AView Earnings Details
11/9/2015Q3 2015($0.56)ViewN/AView Earnings Details
7/23/2015Q2 2015($0.49)ViewN/AView Earnings Details
5/7/2015Q1 2015($0.42)ViewN/AView Earnings Details
2/17/2015Q4 2014($0.35)ViewN/AView Earnings Details
10/30/2014Q314($0.56)$89.70 millionViewN/AView Earnings Details
8/5/2014Q214($0.49)ViewN/AView Earnings Details
5/6/2014Q1 14($0.42)($0.56)$1.96 millionViewN/AView Earnings Details
2/4/2014Q413($0.07)$5.04$2.00 million$35.24 millionViewN/AView Earnings Details
10/31/2013Q313($0.07)($0.14)$2.00 million$1.96 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.07)($0.07)$1.96 millionViewN/AView Earnings Details
4/24/2013Q1 2013($0.07)($0.07)$2.80 million$1.96 millionViewN/AView Earnings Details
2/6/2013Q4 2012($0.14)($0.56)$2.79 million$2.47 millionViewN/AView Earnings Details
11/8/2012Q3 2012($0.07)($0.21)ViewN/AView Earnings Details
8/2/2012Q2 2012($0.02)ViewN/AView Earnings Details
5/8/2012Q1 2012($0.07)$0.01ViewN/AView Earnings Details
2/9/2012Q4 2011($0.14)($0.06)ViewN/AView Earnings Details
11/3/2011Q3 2011($0.14)($0.13)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.14)($0.19)ViewN/AView Earnings Details
2/3/2011Q4 2010($1.50)ViewN/AView Earnings Details
10/28/2010Q3 2010$0.49($0.17)ViewN/AView Earnings Details
7/28/2010Q2 2010($0.21)($0.14)ViewN/AView Earnings Details
4/28/2010Q1 2010($0.17)ViewN/AView Earnings Details
1/28/2010Q4 2009($0.28)($0.05)ViewN/AView Earnings Details
10/29/2009Q3 2009($0.49)($0.22)ViewN/AView Earnings Details
8/4/2009Q2 2009($0.28)($0.01)ViewN/AView Earnings Details
4/30/2009Q1 2009($0.14)($0.30)ViewN/AView Earnings Details
2/5/2009Q4 2008$0.28($0.22)ViewN/AView Earnings Details
10/29/2008Q3 2008$2.10$2.47ViewN/AView Earnings Details
7/30/2008Q2 2008$0.70($0.17)ViewN/AView Earnings Details
5/7/2008Q1 2008$0.42$0.40ViewN/AView Earnings Details
2/7/2008Q4 2007$0.21$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Pain Therapeutics (NASDAQ:PTIE) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.65 EPS
Next Year EPS Consensus Estimate: $-4.85 EPS

Dividends

Pain Therapeutics (NASDAQ:PTIE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/11/2012special$5.2512/13/201212/17/201212/24/2012
(Data available from 1/1/2013 forward)

Insider Trades

Pain Therapeutics (NASDAQ PTIE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 32.70%
Institutional Ownership Percentage: 35.64%
Insider Trades by Quarter for Pain Therapeutics (NASDAQ:PTIE)
Institutional Ownership by Quarter for Pain Therapeutics (NASDAQ:PTIE)

Pain Therapeutics (NASDAQ PTIE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/6/2013Sanford RobertsonDirectorBuy50,000$3.73$186,500.00369,727View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pain Therapeutics (NASDAQ PTIE) News Headlines

Source:
DateHeadline
Gabelli Weighs in on Pain Therapeutics, Inc.s FY2018 Earnings (PTIE)Gabelli Weighs in on Pain Therapeutics, Inc.'s FY2018 Earnings (PTIE)
www.americanbankingnews.com - February 16 at 11:18 AM
Gabelli Comments on Pain Therapeutics, Inc.s FY2022 Earnings (PTIE)Gabelli Comments on Pain Therapeutics, Inc.'s FY2022 Earnings (PTIE)
www.americanbankingnews.com - February 15 at 4:28 PM
TTPH Implodes On IGNITE3, EC Approves 2nd Herceptin Biosimilar, PTIE At It Again - NasdaqTTPH Implodes On IGNITE3, EC Approves 2nd Herceptin Biosimilar, PTIE At It Again - Nasdaq
www.nasdaq.com - February 14 at 3:34 PM
Pain Therapeutics (PTIE) Resubmits NDA for REMOXY ER - StreetInsider.comPain Therapeutics (PTIE) Resubmits NDA for REMOXY ER - StreetInsider.com
www.streetinsider.com - February 14 at 7:38 AM
Pain Therapeutics Resubmits New Drug Application for REMOXY® ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic PainPain Therapeutics Resubmits New Drug Application for REMOXY® ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain
finance.yahoo.com - February 13 at 3:30 PM
Pain Therapeutics refiles U.S. marketing application for Remoxy ER; shares up 3%Pain Therapeutics refiles U.S. marketing application for Remoxy ER; shares up 3%
seekingalpha.com - February 13 at 9:57 AM
Pain Therapeutics (PTIE) to Release Quarterly Earnings on ThursdayPain Therapeutics (PTIE) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - February 8 at 1:24 AM
Pain Therapeutics Reports 2017 Financial Results and Corporate Update - GlobeNewswire (press release)Pain Therapeutics Reports 2017 Financial Results and Corporate Update - GlobeNewswire (press release)
globenewswire.com - February 6 at 7:22 AM
Pain Therapeutics Reports 2017 Financial Results and Corporate UpdatePain Therapeutics Reports 2017 Financial Results and Corporate Update
finance.yahoo.com - February 5 at 3:29 PM
Quotidian Technical Highlights on Selected Biotech Stocks -- PDL BioPharma, Progenics Pharma, Pain Therapeutics, and uniQureQuotidian Technical Highlights on Selected Biotech Stocks -- PDL BioPharma, Progenics Pharma, Pain Therapeutics, and uniQure
www.bizjournals.com - January 19 at 11:38 AM
Gabelli Analysts Raise Earnings Estimates for Pain Therapeutics, Inc. (PTIE)Gabelli Analysts Raise Earnings Estimates for Pain Therapeutics, Inc. (PTIE)
www.americanbankingnews.com - January 12 at 6:54 AM
Zacks: Pain Therapeutics, Inc. (PTIE) Given Average Rating of "Strong Sell" by BrokeragesZacks: Pain Therapeutics, Inc. (PTIE) Given Average Rating of "Strong Sell" by Brokerages
www.americanbankingnews.com - January 10 at 5:30 PM
Earnings Growth Hamper Pain Therapeutics (PTIE) RatingEarnings Growth Hamper Pain Therapeutics (PTIE) Rating
investorplace.com - January 10 at 11:18 AM
PTIE Skyrockets On Remoxy Data, ASND On An Ascent, There Is HOPE For GBTPTIE Skyrockets On Remoxy Data, ASND On An Ascent, There Is HOPE For GBT
www.finanznachrichten.de - January 10 at 10:17 AM
Does Pain Therapeutics Inc’s (NASDAQ:PTIE) Earnings Growth Make It An Outperformer?Does Pain Therapeutics Inc’s (NASDAQ:PTIE) Earnings Growth Make It An Outperformer?
finance.yahoo.com - January 10 at 10:17 AM
Pain Therapeutics, REMOXY Gets Positive Study Results, Updates for FENROCK and PTI-125Pain Therapeutics, REMOXY Gets Positive Study Results, Updates for FENROCK and PTI-125
finance.yahoo.com - January 10 at 10:17 AM
Here’s What’s Moving Axsome Therapeutics and Pain TherapeuticsHere’s What’s Moving Axsome Therapeutics and Pain Therapeutics
finance.yahoo.com - January 10 at 10:17 AM
2 Biotech Stocks Climbing on Positive Findings - Baystreet.ca2 Biotech Stocks Climbing on Positive Findings - Baystreet.ca
www.baystreet.ca - January 9 at 4:46 PM
Mid-Afternoon Market Update: Pain Therapeutics Jumps On Clinical Study Data; Big 5 Sporting Goods Shares Plummet - BenzingaMid-Afternoon Market Update: Pain Therapeutics Jumps On Clinical Study Data; Big 5 Sporting Goods Shares Plummet - Benzinga
www.benzinga.com - January 9 at 4:46 PM
Pain Therapeutics Shares Double On Clinical Study Data - BenzingaPain Therapeutics Shares Double On Clinical Study Data - Benzinga
www.benzinga.com - January 9 at 4:46 PM
2 Biotech Stocks Climbing on Positive Findings2 Biotech Stocks Climbing on Positive Findings
finance.yahoo.com - January 9 at 4:46 PM
Why Pain Therapeutics, Inc. (PTIE) Shares Skyrocketed 150% TodayWhy Pain Therapeutics, Inc. (PTIE) Shares Skyrocketed 150% Today
finance.yahoo.com - January 9 at 4:46 PM
Healthcare Stocks Breakout: Pain Therapeutics, Inc. (PTIE), Global Blood Therapeutics Inc (GBT)Healthcare Stocks Breakout: Pain Therapeutics, Inc. (PTIE), Global Blood Therapeutics Inc (GBT)
finance.yahoo.com - January 9 at 4:46 PM
Mid-Afternoon Market Update: Pain Therapeutics Jumps On Clinical Study Data; Big 5 Sporting Goods Shares PlummetMid-Afternoon Market Update: Pain Therapeutics Jumps On Clinical Study Data; Big 5 Sporting Goods Shares Plummet
feeds.benzinga.com - January 9 at 3:31 PM
Durect up 11% on Pain Therapeutics Remoxy-stoked rallyDurect up 11% on Pain Therapeutics' Remoxy-stoked rally
seekingalpha.com - January 9 at 12:56 PM
Pain Therapeutics Shares Double On Clinical Study DataPain Therapeutics Shares Double On Clinical Study Data
feeds.benzinga.com - January 9 at 12:32 PM
Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™
finance.yahoo.com - January 9 at 10:07 AM
Pain Therapeutics (PTIE) versus Its Peers Head-To-Head ReviewPain Therapeutics (PTIE) versus Its Peers Head-To-Head Review
www.americanbankingnews.com - December 28 at 12:16 AM
Zacks Investment Research Lowers Pain Therapeutics (PTIE) to HoldZacks Investment Research Lowers Pain Therapeutics (PTIE) to Hold
www.americanbankingnews.com - December 27 at 6:24 AM
Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™ - GlobeNewswire (press release)Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™ - GlobeNewswire (press release)
globenewswire.com - December 19 at 4:39 PM
Pain Therapeutics (PTIE) Announces Positive Regulatory Meeting for REMOXY - StreetInsider.comPain Therapeutics (PTIE) Announces Positive Regulatory Meeting for REMOXY - StreetInsider.com
www.streetinsider.com - December 18 at 4:40 PM
Health Care Sector Update for 12/18/2017: ADRO,PTIE,NVIV - NasdaqHealth Care Sector Update for 12/18/2017: ADRO,PTIE,NVIV - Nasdaq
www.nasdaq.com - December 18 at 4:40 PM
Pain Therapeutics, Inc. (PTIE) Short Interest UpdatePain Therapeutics, Inc. (PTIE) Short Interest Update
www.americanbankingnews.com - December 18 at 4:36 PM
Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™ - NasdaqPain Therapeutics Reports Positive Regulatory Meeting for REMOXY™ - Nasdaq
www.nasdaq.com - December 18 at 10:35 AM
Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™
finance.yahoo.com - December 18 at 10:35 AM
Pain Therapeutics (PTIE) Reports New Publication on Alzheimers Disease - StreetInsider.comPain Therapeutics (PTIE) Reports New Publication on Alzheimer's Disease - StreetInsider.com
www.streetinsider.com - December 15 at 4:59 PM
Pain Therapeutics Announces New Publication on Alzheimer’s DiseasePain Therapeutics Announces New Publication on Alzheimer’s Disease
finance.yahoo.com - December 14 at 10:21 AM
Pain Therapeutics (PTIE) and Its Competitors Head-To-Head ReviewPain Therapeutics (PTIE) and Its Competitors Head-To-Head Review
www.americanbankingnews.com - December 9 at 3:14 AM
Reviewing Pain Therapeutics (PTIE) & Its PeersReviewing Pain Therapeutics (PTIE) & Its Peers
www.americanbankingnews.com - December 7 at 9:24 AM
Pain Therapeutics (PTIE) Stock Rating Lowered by ValuEnginePain Therapeutics (PTIE) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - December 2 at 8:28 PM
Pain Therapeutics (PTIE) to Release Earnings on MondayPain Therapeutics (PTIE) to Release Earnings on Monday
www.americanbankingnews.com - November 20 at 1:40 AM
Should You Be Concerned About Pain Therapeutics Inc’s (PTIE) Shareholders?Should You Be Concerned About Pain Therapeutics Inc’s (PTIE) Shareholders?
finance.yahoo.com - November 15 at 7:42 AM
Pain Therapeutics (PTIE) Releases  Earnings ResultsPain Therapeutics (PTIE) Releases Earnings Results
www.americanbankingnews.com - November 2 at 5:19 PM
Pain Therapeutics Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)Pain Therapeutics Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 2 at 7:58 AM
Pain Therapeutics Reports Third Quarter 2017 Financial ResultsPain Therapeutics Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 2 at 7:57 AM
Pain Therapeutics reports 3Q lossPain Therapeutics reports 3Q loss
finance.yahoo.com - November 2 at 7:57 AM
Health Care Sector Update for 10/30/2017: PTIE,CRME,COM.TO,PSTI - NasdaqHealth Care Sector Update for 10/30/2017: PTIE,CRME,COM.TO,PSTI - Nasdaq
www.nasdaq.com - October 31 at 8:16 AM
Pain Therapeutics Announces Upcoming Meeting with FDA - GlobeNewswire (press release)Pain Therapeutics Announces Upcoming Meeting with FDA - GlobeNewswire (press release)
globenewswire.com - October 31 at 8:16 AM
Pain Therapeutics Announces Upcoming Meeting with FDAPain Therapeutics Announces Upcoming Meeting with FDA
finance.yahoo.com - October 31 at 8:16 AM
Analysts Set Expectations for Pain Therapeutics FY2017 Earnings (PTIE)Analysts Set Expectations for Pain Therapeutics' FY2017 Earnings (PTIE)
www.americanbankingnews.com - October 30 at 2:56 AM

SEC Filings

Pain Therapeutics (NASDAQ:PTIE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pain Therapeutics (NASDAQ:PTIE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pain Therapeutics (NASDAQ PTIE) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.